Amneal Pharmaceuticals, Inc. (AMRX)
16.65
-0.57
(-3.31%)
USD |
NASDAQ |
Sep 15, 16:00
16.80
+0.15
(+0.90%)
Pre-Market: 08:51
Amneal Pharmaceuticals Market Cap : 5.317B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 5.317B |
| September 14, 2026 | 5.499B |
| September 11, 2026 | 5.432B |
| September 10, 2026 | 5.387B |
| September 09, 2026 | 5.508B |
| September 08, 2026 | 5.445B |
| September 04, 2026 | 5.569B |
| September 03, 2026 | 5.706B |
| September 02, 2026 | 5.767B |
| September 01, 2026 | 5.646B |
| August 31, 2026 | 5.579B |
| August 28, 2026 | 5.601B |
| August 27, 2026 | 5.751B |
| August 26, 2026 | 5.745B |
| August 25, 2026 | 5.722B |
| August 24, 2026 | 5.678B |
| August 21, 2026 | 5.719B |
| August 20, 2026 | 5.716B |
| August 19, 2026 | 5.783B |
| August 18, 2026 | 5.809B |
| August 17, 2026 | 5.882B |
| August 14, 2026 | 5.796B |
| August 13, 2026 | 5.515B |
| August 12, 2026 | 5.639B |
| August 11, 2026 | 5.461B |
| Date | Value |
|---|---|
| August 10, 2026 | 5.710B |
| August 07, 2026 | 5.793B |
| August 06, 2026 | 5.770B |
| August 05, 2026 | 5.895B |
| August 04, 2026 | 5.901B |
| August 03, 2026 | 6.013B |
| July 31, 2026 | 5.844B |
| July 30, 2026 | 5.901B |
| July 29, 2026 | 6.093B |
| July 28, 2026 | 5.984B |
| July 27, 2026 | 5.771B |
| July 24, 2026 | 5.716B |
| July 23, 2026 | 5.732B |
| July 22, 2026 | 5.662B |
| July 21, 2026 | 5.774B |
| July 20, 2026 | 5.582B |
| July 17, 2026 | 5.694B |
| July 16, 2026 | 5.755B |
| July 15, 2026 | 5.487B |
| July 14, 2026 | 5.324B |
| July 13, 2026 | 5.480B |
| July 10, 2026 | 5.426B |
| July 09, 2026 | 5.429B |
| July 08, 2026 | 5.410B |
| July 07, 2026 | 5.439B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 5.856B |
| Eli Lilly & Co. | 1.070T |
| Viatris, Inc. | 19.23B |
| Harmony Biosciences Holdings, Inc. | 2.451B |
| ANI Pharmaceuticals, Inc. | 1.657B |
Market Cap Related Metrics
| PE Ratio | 34.75 |
| PS Ratio | 1.749 |
| PEG Ratio | 0.0046 |
| Price to Book Value | 160.99 |
| Price | 16.65 |
| Earnings Yield | 2.88% |
| PEGY Ratio | 0.0046 |
| Operating PE Ratio | 11.43 |
| Normalized PE Ratio | 26.80 |